Skip to main content
Erschienen in: Endocrine 2/2017

07.12.2016 | Original Article

The total number of tissue blocks per centimetre of tumor significantly correlated with the risk of distant metastasis in patients with minimally invasive follicular thyroid carcinoma

verfasst von: Brian Hung-Hin Lang, Tony W. H. Shek, Arnold L. H Wu, Koon Yat Wan

Erschienen in: Endocrine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Given that careful histological examination plays a pivotal role in follicular thyroid carcinoma categorization, we hypothesize that the number of blocks taken at initial specimen review may be associated with survival outcomes of patients initially diagnosed with minimally invasive follicular thyroid carcinoma.

Methods

A total of 162 patients with confirmed minimally invasive follicular thyroid carcinoma were analyzed. The number of tissue blocks taken from each patient was recorded and the number of blocks per each centimeter of tumor was calculated. A multivariate analysis was conducted to identify independent factors for distant metastasis-free survival.

Results

After a mean follow-up of 197.88 ± 155.39 months, 7 (4.3%) patients developed distant metastasis during follow-up (group II). Relative to those who remained disease-free (group I), group II were significantly older at initial operation (p = 0.022), had larger tumors (p = 0.002) and fewer number of blocks taken/cm of tumor (p = 0.001). However, after adjusting for age at initial operation and tumor size, total number of tissue blocks taken/cm of tumor was the only independent determinant for distant metastasis-free survival (p = 0.049). The 10-year distant metastasis-free survival was significantly better in those who had ≥ 4 blocks/cm of tumor (n = 82) than those with ≤ 3 block/cm of tumor (n = 80) (100 vs. 84.7%, p = 0.005, by log rank).

Conclusions

Although our study was not able to identify the precise cause for the association between the total number of tissue blocks taken/cm of tumor and distant metastasis-free survival, our data support a more liberal approach in taking tissue blocks on thyroid nodules especially those showing well-differentiated follicular cell differentiation.
Literatur
2.
Zurück zum Zitat B.H. Lang, C.Y. Lo, W.F. Chan, K.Y. Lam, K.Y. Wan, Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre. Endocr. Relat. Cancer 14(1), 29–42 (2007)CrossRefPubMed B.H. Lang, C.Y. Lo, W.F. Chan, K.Y. Lam, K.Y. Wan, Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre. Endocr. Relat. Cancer 14(1), 29–42 (2007)CrossRefPubMed
3.
Zurück zum Zitat C.Y. Lo, W.F. Chan, K.Y. Lam, K.Y. Wan, Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann. Surg. 242(5), 708–715 (2005)CrossRefPubMedPubMedCentral C.Y. Lo, W.F. Chan, K.Y. Lam, K.Y. Wan, Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann. Surg. 242(5), 708–715 (2005)CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat G. Stenson, I.L. Nilsson, N. Mu, C. Larsson, C.I. Lundgren, C.C. Juhlin, A. Höög, J. Zedenius, Minimally invasive follicular thyroid carcinomas: prognostic factors. Endocrine 53(2), 505–511 (2016)CrossRefPubMedPubMedCentral G. Stenson, I.L. Nilsson, N. Mu, C. Larsson, C.I. Lundgren, C.C. Juhlin, A. Höög, J. Zedenius, Minimally invasive follicular thyroid carcinomas: prognostic factors. Endocrine 53(2), 505–511 (2016)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRefPubMedPubMedCentral B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng. WHO classification of tumors. pathology and genetics of tumours of endocrine organs. (IARC Press, Lyon), (2004) R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng. WHO classification of tumors. pathology and genetics of tumours of endocrine organs. (IARC Press, Lyon), (2004)
7.
Zurück zum Zitat J. Rosai, Rosai and Ackerman’s Surgical Pathology, Elsevier, 2011, 2 volume set, 10th Edn. ISBN-13: 978-0323069694, St. Louis, United States J. Rosai, Rosai and Ackerman’s Surgical Pathology, Elsevier, 2011, 2 volume set, 10th Edn. ISBN-13: 978-0323069694, St. Louis, United States
8.
Zurück zum Zitat M.L. Carcangiu, Minimally invasive follicular carcinoma. Endocr. Pathol. 8(3), 231–234 (1997)CrossRefPubMed M.L. Carcangiu, Minimally invasive follicular carcinoma. Endocr. Pathol. 8(3), 231–234 (1997)CrossRefPubMed
10.
Zurück zum Zitat W. Lang, A. Georgii, G. Stauch, E. Kienzle, The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch. A. Pathol. Anat. Histol. 385(2), 125–141 (1980)CrossRefPubMed W. Lang, A. Georgii, G. Stauch, E. Kienzle, The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch. A. Pathol. Anat. Histol. 385(2), 125–141 (1980)CrossRefPubMed
11.
Zurück zum Zitat Y.M. Lee, D.E. Song, T.Y. Kim, T.Y. Sung, J.H. Yoon, K.W. Chung, S.J. Hong, Risk factors for distant metastasis in patients with minimally invasive follicular thyroid carcinoma. PLoS ONE 11(5), e0155489 (2016)CrossRefPubMedPubMedCentral Y.M. Lee, D.E. Song, T.Y. Kim, T.Y. Sung, J.H. Yoon, K.W. Chung, S.J. Hong, Risk factors for distant metastasis in patients with minimally invasive follicular thyroid carcinoma. PLoS ONE 11(5), e0155489 (2016)CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat K.W. Schmid, S.Y. Sheu, R. Görges, C. Ensinger, M. Tötsch, Thyroid tumors. Pathologe 24(5), 357–372 (2003). ReviewCrossRefPubMed K.W. Schmid, S.Y. Sheu, R. Görges, C. Ensinger, M. Tötsch, Thyroid tumors. Pathologe 24(5), 357–372 (2003). ReviewCrossRefPubMed
13.
Zurück zum Zitat K.W. Schmid, N.R. Farid, How to define follicular thyroid carcinoma?. Virchows Arch. 448(4), 385–393 (2006)CrossRefPubMed K.W. Schmid, N.R. Farid, How to define follicular thyroid carcinoma?. Virchows Arch. 448(4), 385–393 (2006)CrossRefPubMed
14.
Zurück zum Zitat P. Goffredo, K. Cheung, S.A. Roman, J.A. Sosa, Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Ann. Surg. Oncol. 20(3), 767–772 (2013)CrossRefPubMed P. Goffredo, K. Cheung, S.A. Roman, J.A. Sosa, Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Ann. Surg. Oncol. 20(3), 767–772 (2013)CrossRefPubMed
15.
Zurück zum Zitat G. Dionigi, J.L. Kraimps, K.W. Schmid, M. Hermann, S.Y. Sheu-Grabellus, P. De Wailly, A. Beaulieu, M.L. Tanda, F. Sessa, Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European society of endocrine surgeons (ESES). Langenbecks Arch. Surg. 399(2), 165–184 (2014)CrossRefPubMed G. Dionigi, J.L. Kraimps, K.W. Schmid, M. Hermann, S.Y. Sheu-Grabellus, P. De Wailly, A. Beaulieu, M.L. Tanda, F. Sessa, Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European society of endocrine surgeons (ESES). Langenbecks Arch. Surg. 399(2), 165–184 (2014)CrossRefPubMed
16.
Zurück zum Zitat P. Goffredo, C. Jillard, S. Thomas, R.P. Scheri, J.A. Sosa, S. Roman, Minimally invasive follicular carcinoma: predictors of vascular invasion and impact on patterns of care. Endocrine 51(1), 123–130 (2016)CrossRefPubMed P. Goffredo, C. Jillard, S. Thomas, R.P. Scheri, J.A. Sosa, S. Roman, Minimally invasive follicular carcinoma: predictors of vascular invasion and impact on patterns of care. Endocrine 51(1), 123–130 (2016)CrossRefPubMed
17.
Zurück zum Zitat K. Sugino, K. Kameyama, M. Nagahama, W. Kitagawa, H. Shibuya, K. Ohkuwa, T. Uruno, J. Akaishi, A. Suzuki, C. Masaki, K. Matsuzu, M. Kawano, K. Ito, Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid? Ann. Surg. Oncol. 21(9), 2981–2986 (2014). SepCrossRefPubMed K. Sugino, K. Kameyama, M. Nagahama, W. Kitagawa, H. Shibuya, K. Ohkuwa, T. Uruno, J. Akaishi, A. Suzuki, C. Masaki, K. Matsuzu, M. Kawano, K. Ito, Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid? Ann. Surg. Oncol. 21(9), 2981–2986 (2014). SepCrossRefPubMed
18.
Zurück zum Zitat K. Sugino, K. Kameyama, K. Ito, M. Nagahama, W. Kitagawa, H. Shibuya, K. Ohkuwa, Y. Yano, T. Uruno, J. Akaishi, A. Suzuki, C. Masaki, K. Ito, Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid 22(8), 798–804 (2012)CrossRefPubMed K. Sugino, K. Kameyama, K. Ito, M. Nagahama, W. Kitagawa, H. Shibuya, K. Ohkuwa, Y. Yano, T. Uruno, J. Akaishi, A. Suzuki, C. Masaki, K. Ito, Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid 22(8), 798–804 (2012)CrossRefPubMed
Metadaten
Titel
The total number of tissue blocks per centimetre of tumor significantly correlated with the risk of distant metastasis in patients with minimally invasive follicular thyroid carcinoma
verfasst von
Brian Hung-Hin Lang
Tony W. H. Shek
Arnold L. H Wu
Koon Yat Wan
Publikationsdatum
07.12.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1188-y

Weitere Artikel der Ausgabe 2/2017

Endocrine 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.